Tenet Welcomes Silicon Valley Entrepreneur and AI Veteran Dr. George Krucik to its Board of Directors
Tenet Fintech Group Inc. (CSE: PKK) (OTC Pink: PKKFF) has appointed Dr. George Krucik to its Board of Directors. Dr. Krucik, a Silicon Valley veteran with nearly 40 years of experience, brings expertise in medicine, computer science, and AI. He is the founder and CTO of iTreatMD, an AI-powered Electronic Medical Record platform. Dr. Krucik's appointment aligns with Tenet's increased focus on AI, data analysis, and U.S. expansion.
Dr. Krucik will contribute to the development of Tenet's Equity Insider product, which aims to infer public company financial results before they are officially released. He replaces Mr. Sanjay Sharma on the Board, who resigned to reduce his workload and spend more time with family.
Tenet Fintech Group Inc. (CSE: PKK) (OTC Pink: PKKFF) ha nominato Dr. George Krucik nel suo Consiglio di Amministrazione. Il Dr. Krucik, un veterano della Silicon Valley con quasi 40 anni di esperienza, porta con sé competenze in medicina, informatica e intelligenza artificiale. È il fondatore e CTO di iTreatMD, una piattaforma di Cartelle Mediche Elettroniche alimentata dall'IA. La nomina del Dr. Krucik si allinea con il crescente interesse di Tenet nel AI, nell'analisi dei dati e nell'espansione negli Stati Uniti.
Il Dr. Krucik contribuirà allo sviluppo del prodotto Equity Insider di Tenet, che mira a inferire i risultati finanziari delle aziende pubbliche prima della loro ufficializzazione. Sostituisce il Sig. Sanjay Sharma nel Consiglio, il quale si è dimesso per ridurre il suo carico di lavoro e trascorrere più tempo con la famiglia.
Tenet Fintech Group Inc. (CSE: PKK) (OTC Pink: PKKFF) ha nombrado al Dr. George Krucik en su Junta Directiva. El Dr. Krucik, un veterano de Silicon Valley con casi 40 años de experiencia, aporta conocimientos en medicina, informática e IA. Es el fundador y CTO de iTreatMD, una plataforma de Registros Médicos Electrónicos impulsada por IA. La designación del Dr. Krucik está en línea con el creciente enfoque de Tenet en IA, análisis de datos y expansión en EE. UU..
El Dr. Krucik contribuirá al desarrollo del producto Equity Insider de Tenet, que busca inferir los resultados financieros de las empresas públicas antes de que sean anunciados oficialmente. Reemplaza al Sr. Sanjay Sharma en la Junta, quien renunció para reducir su carga de trabajo y pasar más tiempo con su familia.
Tenet Fintech Group Inc. (CSE: PKK) (OTC Pink: PKKFF)는 Dr. George Krucik을 이사회의 신임 이사로 임명했습니다. Krucik 박사는 실리콘 밸리에서 거의 40년의 경험을 가진 전문가로, 의학, 컴퓨터 과학 및 인공지능 분야에서 전문성을 제공합니다. 그는 iTreatMD의 창립자이자 CTO로, 인공지능 기반의 전자 의료 기록 플랫폼입니다. Krucik 박사의 임명은 Tenet이 인공지능, 데이터 분석 및 미국 시장 확장에 더욱 집중한다는 방침과 일치합니다.
Krucik 박사는 Tenet의 Equity Insider 제품 개발에 기여할 예정이며, 이 제품은 공기업의 재무 결과를 공식 발표 전에 추론하는 것을 목표로 합니다. 그는 이사회에서 Sanjay Sharma 씨를 대신하게 되며, Sharma 씨는 업무 부담을 줄이고 가족과 더 많은 시간을 보내기 위해 사임했습니다.
Tenet Fintech Group Inc. (CSE: PKK) (OTC Pink: PKKFF) a nommé Dr. George Krucik au sein de son Conseil d'Administration. Le Dr. Krucik, un vétéran de la Silicon Valley avec près de 40 ans d'expérience, apporte son expertise en médecine, informatique et IA. Il est le fondateur et CTO de iTreatMD, une plateforme de dossiers médicaux électroniques alimentée par l'IA. La nomination du Dr. Krucik s'inscrit dans l'engagement croissant de Tenet en faveur de l'IA, de l'analyse de données et de l'expansion aux États-Unis.
Le Dr. Krucik contribuera au développement du produit Equity Insider de Tenet, qui vise à inférer les résultats financiers des entreprises publiques avant leur publication officielle. Il remplace M. Sanjay Sharma au Conseil, qui a démissionné pour alléger sa charge de travail et passer plus de temps avec sa famille.
Tenet Fintech Group Inc. (CSE: PKK) (OTC Pink: PKKFF) hat Dr. George Krucik in seinen Vorstand berufen. Dr. Krucik, ein Veteran aus dem Silicon Valley mit fast 40 Jahren Erfahrung, bringt Fachkenntnisse in den Bereichen Medizin, Informatik und KI mit. Er ist der Gründer und CTO von iTreatMD, einer KI-gestützten Plattform für Elektronische Patientenakten. Die Ernennung von Dr. Krucik entspricht Tenets verstärktem Fokus auf KI, Datenanalyse und Expansion in die USA.
Dr. Krucik wird zur Entwicklung von Tenets Equity Insider-Produkt beitragen, das darauf abzielt, die finanziellen Ergebnisse von Unternehmen vor deren offizieller Veröffentlichung zu ermitteln. Er ersetzt Herr Sanjay Sharma im Vorstand, der zurückgetreten ist, um seine Arbeitslast zu reduzieren und mehr Zeit mit seiner Familie zu verbringen.
- Appointment of Dr. George Krucik, an experienced AI and medical technology expert, to the Board of Directors
- Potential development of Equity Insider product to infer public company financial results before official release
- Alignment with company's strategic focus on AI, data analysis, and U.S. expansion
- None.
Toronto, Ontario--(Newsfile Corp. - September 3, 2024) - Tenet Fintech Group Inc. (CSE: PKK) (OTC Pink: PKKFF) ("Tenet" or the "Company"), an innovative analytics service provider, owner and operator of the Cubeler® Business Hub, today announced the appointment of Dr. George Krucik to its Board of Directors (the "Board").
Dr. Krucik is a physician, inventor, entrepreneur, senior executive and early adopter of AI that has spent almost 40 years in Silicon Valley, where his unique combination of expertise in the medical field, computer science and AI has seen him bring to market several innovative online and cloud-based medical products, and has led to an impressive patent portfolio. Dr. Krucik is currently the founder and CTO of iTreatMD (https://www.itreatmd.com/), an Office of the National Coordinator for Health Information Technology (ONC) certified Electronic Medical Record (EMR) platform that leverages AI and machine learning to simplify medical professionals' documentation processes. iTreatMD aggregates data for each patient and knowledge on how to best treat their conditions, and auto populates this information on the medical professionals' notes as part of their workflows, thus radically redefining workflows and documentation processes in the space. Prior to founding iTreatMD, Dr. Krucik spent several years in management and executive positions at both private and public companies, including Editor-in-Chief at Healthline.com, Product Manager at Salesforce.com, and CEO of Autodesk Australia.
"I am a strong believer that AI can be applied in various industries to dramatically and positively impact the way the industries operate, which is our objective for EMRs with iTreatMD in the medical space," commented Dr. Krucik. "Being familiar with the process and timing of filing financial results at public companies, I find Tenet's idea of using AI to potentially infer public company financial results before they are made public very intriguing. I very much look forward to working with Tenet's Chief Analytics Officer, Dr. Luis Rocha, Tenet's data science team and capital markets consultants to contribute in any way I can to help bring Tenet's Equity Insider product offering to market. I also look forward to working with the other members of Tenet's executive team and Board of Directors on the Company's strategic vision as it puts increasingly more emphasis on AI, data analysis and U.S. expansion," concluded Dr. Krucik.
Dr. Krucik has a Bachelor of Science degree in Computer Science and Mathematics from the University of Manitoba, a Medical Doctor degree from the University of Manitoba and Master of Business Administration from the University of San Francisco. Dr. Krucik will be replacing Mr. Sanjay Sharma on the Board as Mr. Sharma tendered his resignation from the Board to reduce his professional workload and to spend more time with his family.
About Tenet Fintech Group Inc.:
Tenet Fintech Group Inc. is the parent company of a group of innovative financial technology (Fintech) and artificial intelligence (AI) companies. All references to Tenet in this news release, unless explicitly specified, include Tenet and all its subsidiaries. Tenet's subsidiaries offer various analytics and AI-based products and services to businesses, capital markets professionals, government agencies and financial institutions either through or leveraging data gathered by the Cubeler® Business Hub, a global ecosystem where analytics and AI are used to create opportunities and facilitate B2B transactions among its members. Please visit our website at: https://www.tenetfintech.com/.
For more information, please contact:
Tenet Fintech Group Inc.
Mayco Quiroz, Chief Operating Officer
514-340-7775 ext.: 510
investors@tenetfintech.com
CHF Capital Markets
Cathy Hume, CEO
416-868-1079 ext.: 251
cathy@chfir.com
Follow Tenet Fintech Group Inc. on social media:
X: @Tenet_Fintech
Facebook: @Tenet
LinkedIn: Tenet
YouTube: Tenet Fintech
Forward-looking information
Certain statements in this press release constitute forward-looking statements within the meaning of applicable securities laws. Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements are not guarantees of future performance and involve risks, uncertainties and other factors which may cause actual results, performance or achievements of Tenet to be materially different from the outlook or any future results, performance or achievements implied by such statements. Accordingly, readers are advised not to place undue reliance on forward-looking statements. Important risk factors that could affect the forward-looking statements in this news release include, but are not limited to, holding company with significant operations in China; general economic and business conditions, including factors impacting the Company's business in China such as pandemics and COVID-19; legislative and/or regulatory developments; Global Financial conditions, repatriation of profits or transfer of funds from China to Canada, operations in foreign jurisdictions and possible exposure to corruption, bribery or civil unrest; actions by regulators; uncertainties of investigations, proceedings or other types of claims and litigation; timing and completion of capital programs; liquidity and capital resources, negative operating cash flow and additional funding, dilution from further financing; financial performance and timing of capital; and other risks detailed from time to time in reports filed by Tenet with securities regulators in Canada. Reference should also be made to Management's Discussion and Analysis (MD&A) in Tenet's annual and interim reports, Annual Information Form, filed with Canadian securities regulators and available via the System for Electronic Document Analysis and Retrieval (SEDAR+) under Tenet's profile at www.sedarplus.ca, for a description of major risk factors relating to Tenet. Although Tenet has attempted to identify certain factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended.
Forward-looking statements reflect information as of the date on which they are made. The Company assumes no obligation to update or revise forward-looking statements to reflect future events, changes in circumstances, or changes in beliefs, unless required by applicable securities laws. In the event the Company does update any forward-looking statement, no inference should be made that the Company will make additional updates with respect to that statement, related matters, or any other forward-looking statement.
Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/221905
FAQ
Who is the new Board member appointed by Tenet Fintech Group (PKKFF)?
What is Dr. George Krucik's background and expertise?
What is Tenet Fintech Group's (PKKFF) new product mentioned in the announcement?
How does Dr. Krucik's appointment align with Tenet Fintech Group's (PKKFF) strategy?
